EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Building the Bridge: How B2B Media Is Shaping the Future of Chemical Engineering
The shift is already well underway BB medias value used to be measured in reach how many engineers received your magazine how many clicks your digital...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Forgotten Biology: The Missing Link Behind Trial Outcomes
Clinical trials are often described as the science of uncertainty and that uncertainty is expected It is how evidence is built However not all uncertainty is scientific In many cases it arises when the biological context of an intervention is not carried through into the study population
-
Techno Trends
FORE Biotherapeutics Receives FDA Breakthrough Therapy Designation for Plixorafenib in Brain Cancer
FORE Biotherapeutics has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for its investigational drug plixorafenib developed for the treatment of adult patients with BRAF VEmutated highgrade glioma a severe form of brain cancer
-
Projects
Cambrex Announces $150 Million Expansion across U.S. and European Facilities
Cambrex has revealed significant progress on its expansion initiatives across the United States and Europe These projects are designed to boost capacity for manufacturing complex drugs
-
Research Insights
Gene expression and metadata based identification of key genes for lung cancer, COPD, and IPF using machine learning and statistical models
Lung cancer LC is one of the most prevalent and deadly cancers globally presenting a major public health challenge Patients with chronic obstructive pulmonary disease COPD and idiopathic pulmonary fibrosis
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Solutions from Technology to Innovation: Transforming Pharmaceutical Production in North America
Kate Williamson
The integration of technology is reshaping pharmaceutical production in North America, with automation, data analytics, 3D printing, regulatory compliance tools, blockchain, and remote monitoring play...
-
2
The Procedure of Pharmaceutical Development
Xiaoya Zhang
Pharmaceutical development is the identification and evaluation of cycles needs to change over a functioning drug fixing into a medication item reasonable for its expected reason. In the beginning pha...
-
3
Advanced Hot Melt Extrusion: Pioneering Techniques in Pharmaceutical Formulation
Kate Williamson
Hot Melt Extrusion (HME) in pharmaceuticals has revolutionized drug delivery by enhancing solubility, controlling release profiles, and enabling combination therapies. Advanced techniques like twin-sc...
-
4
Advancements in Biologics: Innovations and Regulatory Challenge
Debi Jones
Smart packages are changing the approaches to disease treatment with products such as monoclonal antibodies, gene and cell therapies, biosimilars. These advancements offer new therapies, yet they impo...
-
5
The Role of CROs and CMOs in Accelerating Pharmaceutical Growth
Kate Williamson
Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) are very vital in the progress of the pharmaceutical business. Thus, being able to present their own research, cl...
press releasesRead more...
Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors
Immunome Inc Nasdaq IMNM a biotechnology company committed to developing firstinclass and bestinclass targeted cancer therapies today announced the submission of a New Drug Application NDA to the US Food and Drug Administration
Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
Insilico Medicine a clinicalstage generative AIdriven drug discovery company today announced that the inhalation solution of Rentosertib ISM the companys firstinclass drug candidate with AIidentified novel target
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
CRay Therapeutics Chengdu Co Ltd today announced that its Type II Drug Master File DMF for COPPER Cu CHLORIDE FOR RADIOLABELLING has been listed as active by the US Food and Drug Administration
Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.
Xcovery Holdings Inc Xcovery an evidencebased innovationdriven pharmaceutical company today announced an agreement with EVERSANA a leading provider of commercialization services to the global life sciences
Events Read more...
05 - 06
May 2026GENAP Summit 2026
Vienna, Austria
06 - 07
May 20262nd Edition MaxPotent Pharma Summit 2026
Milan, Italy
06 - 07
May 202641th pharmacovigilance USA 2026
Boston, USA
07 - 08
May 202621st PPM for Pharma & Biotech
New Jersey, USA
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
20 - 21
May 2026Pharma Partnering EU Summit 2026
Basel Marriott Hotel, Switzerland
LATEST NEWSRead more...
FDA Greenlights Advanced Biopharma Manufacturing Tech
The US FDA has approved a cuttingedge biopharma manufacturing platform that promises to streamline production processes and reduce costs for American drug manufacturers
Expression Therapeutics Secures FDA Fast Track and Rare Paediatric Disease Designations for Haemophilia A Therapy
Expression Therapeutics has received Fast Track and Rare Paediatric Disease designations from the US Food and Drug Administration for its investigational autologous stem cell therapy for haemophilia A
Formosa Pharmaceuticals and SERI Partner to Advance Ophthalmic Treatments for Corneal Diseases
Formosa Pharmaceuticals has entered into a strategic research partnership with the Singapore Eye Research Institute SERI to develop nextgeneration ophthalmic formulations for corneal and ocular surface diseases
Chiesi Acquires KalVista for $1.9B in Rare Disease Strategy
Chiesi Farmaceutici is acquiring KalVista Pharmaceuticals for billion to bolster its rare disease offerings with the approved HAE therapy Ekterly
Gilead Sciences completes acquisition of Arcellx ahead of potential anito-cel launch
Gilead Sciences has completed its acquisition of Arcellx strengthening its position ahead of a possible commercial launch of anitocabtagene autoleucel anitocel
Pfizer Extends Patent for Rare Disease Blockbuster
Pfizer announces key licensing deals to prolong patent exclusivity on its leading rare disease therapy bolstering longterm revenue projections amid competitive biopharma landscape
